Stock Evaluator: Solventum Corporation (SOLV)

Solventum Corporation SOLV

$85.19 -1.63 -1.88%
July 31, 2026 12:01:12 PM EST November 10, 2021 Volume: 186,567
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Commentary & Analysis


Financial Summary

Share Statistics SOLV Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $15,035.0 $334.8 83%
Shares Out (Mil) 175.5 41.7 74%
Institutional Ownership 99.7% 77.3% 93%
Float (Mil) 147.1 34.7 69%
Beta 0.72 0.86 42%
Avg Daily Volume (000s) 1,116 266 73%
Price Change
(52-week)
18.0% 60.7% 60%
Growth SOLV Industry
Median
Percentile
(All Stocks)
Sales (5yr) 2.7% 11.8% 26%
Net Income (5yr) 6.5% (5.8%) 49%
EPS (5yr) na 10.7% na
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) na (16.1%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 11 15 15
Current EPS $1.906 $6.551 $7.089
Month Ago EPS $1.892 $6.547 $7.047
# Rev Up 1 0 1
# Rev Down 0 1 0
Three Months Ago EPS $1.663 $6.459 $6.975
Year/Year Chg 2,623% (26.2%) (12.8%)
Financials SOLV Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $8,262 $152 82%
Net Income (TTM) (Mil) $1,432 ($11) 90%
EPS (TTM) $8.219 ($0.500) 93%
Operating Cash Flow (TTM) (Mil) $151 ($2) 56%
Net Cash Flow (TTM) (Mil) $21 $1 63%
Long-Term Debt (Q1) (Mil) $4,785 $22 85%
Enterprise Value (Q1) (Mil) $17,749 $304 82%
Valuation SOLV Industry
Median
Percentile
(All Stocks)
P/B 3.03 2.88 65%
P/E 10.6 30.5 18%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios SOLV Industry
Median
Percentile
(All Stocks)
Gross Margin 53.7% 59.1% 66%
Net Margin 17.3% (7.7%) 76%
ROA 10.0% (13.7%) 87%
ROE 34.8% (15.9%) 89%
Liabilities to Assets 64.8% 44.9% 60%
F-Score 5 4 51%

Solventum Corporation did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors